Analysis on Emergency Authorization Policies of Medical Products

WANG Xue,ZUO Shu-ning,XU Shu-hong,ZHANG Qi,ZHANG Lin-qi,WANG Tao
DOI: https://doi.org/10.3969/j.issn.1003-3734.2021.07.004
2021-01-01
Abstract:The outbreak of pneumonia caused by novel coronavirus reminds us of the importance of strengthening China's capacity in order to respond to public health emergencies. Rapid and effective emergency authorization system of medical products is an important tool to deal with public health emergencies. This paper provides a reference for China to build up the authorization system of medical products under emergency situations by sorting out the emergency authorization policies of the United States in response to public health emergencies. © 2021, Chinese Journal of New Drugs Co. Ltd. All right reserved.
What problem does this paper attempt to address?